Vave Health Addresses the Prohibitive Cost of Medical Imaging

mJOULE Launches in the United Kingdom Reports Sciton

"Sciton is dedicated to worldwide support and growth. We continue to demonstrate our commitment to developing high quality devices and marketing efforts for our physician and medspa partners worldwide." says Lacee J. Naik, Vice President of Marketing and Public Relations.

FDA Issues Draft Guidance on Remanufacturing and Discussion Paper Seeking Feedback on Cybersecurity Servicing of Medical Devices

With this in mind, the FDA is issuing today's draft guidance to help clarify whether activities performed on medical devices are likely remanufacturing as well as a discussion paper on cybersecurity servicing of devices.

Irrimax Receives FDA Clearance for Irrisept

"This new clearance from the FDA further solidifies Irrisept as the market leader in wound irrigation," said Mark Alvarez, CEO of Irrimax.

October 27, 2020

Vave Health is addressing the prohibitive cost of medical imaging by offering clinicians and medical students a portable device to provide enhanced care no matter one’s physical location or environmental barriers. The company are makers of innovative handheld ultrasound technology. With various subscription plans available, Vave Health provides a new model for imaging technology that is making ultrasounds more accessible to providers, patients, and today’s rising medical professionals.

Vave Health is backed by a team of industry leaders and experienced engineers and is rapidly growing, and is well-positioned to revolutionize the physician-patient experience through innovative, industry-transforming technologies. With the recent appointment of Dr. Renee Dversdal as chief medical officer, the company is also actively recruiting for a satellite office in the Seattle market and sets its sights on 2021 for continued growth. Vave Health is also expanding its Global Health Program in the coming months to provide improved access to ultrasound imaging throughout developing countries in Africa and other remote parts of the world.

Vave Health’s unique subscription model is able to provide users with flexible options to fit their needs and offers an industry-first complimentary upgrade to the latest probe every 24 months. Subscription includes the Vave wireless probe with various scanning modes, a battery, charger, and standard warranty. All Vave members can also access on-demand education and advice from Vave’s clinician partners.

“With our ultrasound platform-as-a-service model, we’re able to offer users uncompromised quality at an accessible price point. We can now provide partners with a platform that evolves with them,” said Amin Nikoozadeh, CEO and founder, Vave Health. “Clinicians, health systems, and medical students can now equip themselves to provide enhanced medical care no matter where they are through a unique and all-inclusive service, which provides a wireless probe, access to mentors and free upgrades every 24 months.”

Vave Health also recently announced a partnership with Touro University Nevada, addressing the need to provide the next generation of physicians easy access to medical imaging and training. The partnership supplies students at Touro, which is Nevada’s largest school of medicine and the state’s only school of osteopathic medicine, with a personal wireless Vave Health ultrasound and an ongoing Vave EduPlus Membership.

The Vave ultrasound device was designed with the input of leading health care professionals to create a disruptive technology that is truly affordable and accessible. The cordless device allows users to practice untethered scanning and view clinical images on a smartphone via Vave’s mobile application. Vave Health products and services are commercially available to health systems, physicians, and medical schools and students. Vave’s products and services are available for use by a licensed healthcare professional.

spot_img

DON'T MISS

Hyperfine Adds Medtech Leader and Visionary Scott Huennekens as Executive Chairman

Mr. Huennekens’ public boards include Chairman of Acutus Medical (IPO August 2020); Chairman of Envista (IPO September 2019); and board member of Nuvasive. He also serves as a board member and past Chairman of the Medical Device Manufacturer’s Association (MDMA).

One Drop Reports Carrie Siragusa, CPA Appointed VP of Commercial Strategy, Biosensor

Formerly Head of Innovation and Diabetes Portfolio at Sanofi, Siragusa will be part of a team bringing a multi-analyte dermal sensor (biosensor) with continuous health sensing capabilities to market with a mission to provide broader access to continuous glucose monitoring.

Barbara Moorhouse Appointed as Medica Non-Executive Director

Barbara has extensive business and management experience in the private, public, and regulated sectors.

Subscribe to Medical Device News Magazine here.

Related Articles